overview of 4 fda approvals in acute myeloid leukemia
Published 6 years ago • 292 plays • Length 2:26
Download video MP4
Download video MP3
Similar videos
-
1:31
selecting the appropriate patients for targeted therapies in acute myeloid leukemia
-
8:45
fda approvals in gvhd, crc, and aml, a priority review in mcl, and more
-
0:52
four approved frontline treatments benefit patients with chronic myeloid leukemia
-
3:22
case-based overview: newly diagnosed acute myeloid leukemia
-
1:14
dr. mims on fda approval of ivosidenib in patients with aml
-
8:48
fda approval in aml, priority review designation in nsclc, and more
-
1:16
dr. mannis on targeted agents in the treatment of patients with aml
-
8:51
fda approvals in nets, breast cancer, aml, a biosimilar, and more
-
0:54
overview of advances in recent years for patients with aml
-
7:11
review on 2016 fda approvals, halt on aml trials, and more
-
0:58
using antibody-drug conjugates for treatment of aml
-
11:50
fda approval in myeloma, priority review in dlbcl, application accepted of a biosimilar, and more
-
52:20
acute myeloid leukemia: incorporating novel treatment approaches into clinical pathways
-
41:15
acute myeloid leukemia: examining the pharmacologic profiles and integration of treatment advances
-
9:10
fda approvals in cml and hodgkin lymphoma, priority review in crc, and more
-
0:47
dr. winer discusses the fda approval of ivosidenib in aml
-
8:45
what are some of the fda approved treatments for relapsed or refractory aml?
-
12:40
fda approval in aml, priority review in prostate cancer, ema chmp recommendations, and more
Clip.africa.com - Privacy-policy